|
|
Volumn 270, Issue 37, 1995, Pages 21429-21432
|
|
Topoisomerase poisons: Harnessing the dark side of enzyme mechanism
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 CYCLOPROPYL 6,8 DIFLUORO 1,4 DIHYDRO 7 (4 HYDROXYPHENYL) 4 OXO 3 QUINOLINECARBOXYLIC ACID;
AMSACRINE;
CAMPTOTHECIN;
CIPROFLOXACIN;
CP 115953;
DNA TOPOISOMERASE;
DOXORUBICIN;
ELLIPTICINE;
ETOPOSIDE;
MITOXANTRONE;
NALIDIXIC ACID;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SAINTOPIN;
TOPOTECAN;
UNCLASSIFIED DRUG;
DNA DRUG COMPLEX;
DRUG EFFECT;
DRUG MECHANISM;
ENZYME ACTIVITY;
ENZYME ANALYSIS;
ENZYME INHIBITION;
ENZYME MECHANISM;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
ANIMAL;
BACTERIA;
CELL DEATH;
DNA;
DNA REPLICATION;
DNA TOPOISOMERASES, TYPE I;
DNA TOPOISOMERASES, TYPE II;
ENZYME INHIBITORS;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
|
|
EID: 0029144134
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.270.37.21429 Document Type: Short Survey |
|
Times cited : (511)
|
|
References (0)
|
